Gujarat Inject Kerala Ltd
SUBMISSION OF UNAUDITED FINANCIAL RESULTS AS ON 30.06.2026.
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 15 Jul 2026, 10:02 AM IST · BSE ID: 803e0d17-a894-4365-9448-d7683427a642
View Original BSE Filing (PDF)
💡
In Simple Terms
Gujarat Inject Kerala Ltd approved its first-quarter financial results for FY27, reporting earnings of Rs. 0.86 per share.
🤖 AI Summary
- Gujarat Inject Kerala Ltd Board approved unaudited financial results for the quarter ended June 30, 2026.
- Basic Earnings Per Share (EPS) from continuing operations for Q1 FY27 was Rs. 0.86.
- Diluted Earnings Per Share (EPS) from continuing operations for Q1 FY27 was also Rs. 0.86.
- M/s. S Mandawat & Co., Statutory Auditors, issued a 'Limited Review Report' on the results, which was noted.
- The Board meeting commenced at 09:00 a.m. and concluded at 09:45 a.m. on July 15, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Basic earnings per share (not annualised for quarter ended)
Rs. 0.86
Diluted earnings per share (not annualised for quarter ended)
Rs. 0.86
🏢 How This Affects the Company
The company's earnings per share for the quarter ending June 30, 2026, were Rs. 0.86.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are indirectly affected as the financial results provide an update on the company's performance and profitability for the quarter.
🔍
Management Signal
The management's approval of the unaudited results and taking the Limited Review Report on record signals adherence to regulatory disclosure requirements.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 unaudited financial results — to assess ongoing earnings trends.
Full income statement details for Q1 FY27 — for a complete financial overview.
Any further announcements regarding business operations or strategic direction.
LOW RISK
The filing is a routine financial results announcement, not indicating new risks.
💡 Investor Takeaway
Gujarat Inject Kerala Ltd reported Basic EPS of Rs. 0.86 for the first quarter ended June 30, 2026. This unaudited result provides an initial financial update for FY27, with the Limited Review Report taken on record by the Board.
⚖️ Strengths & Concerns
✅ Positives
- The company demonstrated profitability with Basic Earnings Per Share from continuing operations at Rs. 0.86 for Q1 FY27.
- Diluted Earnings Per Share from continuing operations also stood at Rs. 0.86, aligning with basic EPS for Q1 FY27.
⚠️ Concerns
- The filing does not provide a full income statement or balance sheet details, limiting comprehensive financial analysis.
- Prior period comparable figures are not directly available in this specific filing for a direct year-on-year EPS comparison.
📅 Company Track Record
Gujarat Inject Kerala Ltd's FY26 revenue increased by 91% to Rs. 36.32 crore. A media release in May 2026 indicated rebranding to focus on solar activities. The company reported Q1 FY27 EPS of Rs. 0.86 in this filing.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Gujarat Inject Kerala Ltd's Basic EPS for the quarter ended June 30, 2026?
Gujarat Inject Kerala Ltd reported a Basic Earnings Per Share (EPS) of Rs. 0.86 for the first quarter ended June 30, 2026.
What was Gujarat Inject Kerala Ltd's Diluted EPS for Q1 FY27?
The Diluted Earnings Per Share (EPS) for Gujarat Inject Kerala Ltd for the quarter ended June 30, 2026, was Rs. 0.86.
Who reviewed the Q1 FY27 financial results for Gujarat Inject Kerala Ltd?
M/s. S Mandawat & Co., Statutory Auditors of Gujarat Inject Kerala Ltd, issued a 'Limited Review Report' on the unaudited financial results for the quarter ended June 30, 2026.
Questions based on this BSE filing only. For information purposes.